World's Best Scientists 2026 revealed!
Award Badge
Medicine
Germany
2026

D-Index & Metrics

Medicine

D-Index
158
Citations
98443
World Ranking
847
National Ranking
40

Research.com Recognitions

  • 2026 - Research.com Medicine in Germany Leader Award

Overview

Jürgen Braun is affiliated with the Rheumazentrum Ruhrgebiet in Germany and specializes in research within the field of Medicine, with a particular focus on Rheumatology. Their scholarly contributions include work in subfields such as Immunology, Hematology, Orthopedics and Sports Medicine, and Pathology and Forensic Medicine.

The scientist's research covers various topics, prominently including:

  • Spondyloarthritis Studies and Treatments
  • Rheumatoid Arthritis Research and Therapies
  • Psoriasis: Treatment and Pathogenesis
  • Autoimmune and Inflammatory Disorders Research
  • Bone and Joint Diseases
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Spine and Intervertebral Disc Pathology

Selected recent papers authored by or associated with Jürgen Braun include:

  • Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study, 2020, Arthritis & Rheumatology
  • Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial, 2024, The Lancet
  • Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature, 2023, Annals of the Rheumatic Diseases
  • Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register, 2021, Annals of the Rheumatic Diseases
  • The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA-B27 Status?, 2020, Arthritis Care & Research

Jürgen Braun has collaborated frequently with several researchers in the field. Notable frequent co-authors include:

  • Xenofon Baraliakos
  • Uta Kiltz
  • Ioana Andreica
  • David Kiefer
  • Styliani Tsiami

The scientist has published extensively in several key journals, reflecting their research interests and professional focus. Frequent publication venues comprise:

  • Annals of the Rheumatic Diseases
  • Zeitschrift für Rheumatologie
  • RMD Open
  • Lara D. Veeken
  • The Journal of Rheumatology

Best Publications

  • The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

    M Rudwaleit;D van der Heijde;R Landewé;J Listing

  • The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis

    J. Sieper;M. Rudwaleit;X. Baraliakos;J. Brandt

  • 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

    Désirée van der Heijde;Sofia Ramiro;Robert Landewé;Xenofon Baraliakos

  • Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

    J Braun;J Brandt;J Listing;A Zink

  • 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J Braun;R van den Berg;X Baraliakos;H Boehm

  • Prevalence of spondylarthropathies in HLA‐B27 positive and negative blood donors

    Jürgen Braun;Mathias Bollow;Gerold Remlinger;Ulrich Eggens

  • The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

    M Rudwaleit;R Landewé;D van der Heijde;J Listing

  • Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

    Désirée van der Heijde;Alan Kivitz;Michael H. Schiff;Joachim Sieper

  • Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

    Dominique Baeten;Joachim Sieper;Jürgen Braun;Xenofon Baraliakos

  • Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis

    Ernst Feldtkeller;Muhammad Asim Khan;Désirée van der Heijde;Sjef van der Linden

  • European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.

    L Gossec;J S Smolen;S Ramiro;M de Wit

  • Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis

    C Lukas;R Landewé;J Sieper;M Dougados

  • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

    D. E. Furst;E. C. Keystone;J. Braun;F. C. Breedveld

  • Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).

    Désirée van der Heijde;Ben Dijkmans;Piet Geusens;Joachim Sieper

  • ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J. Zochling;D. Van Der Heijde;R. Burgos-Vargas;E. Collantes

  • Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group

    M. Rudwaleit;A. G. Jurik;K.-G. A. Hermann;R. Landewé

  • Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.

    John C. Davis;Désirée Van Der Heijde;Jurgen Braun;Maxime Dougados

  • Ankylosing spondylitis: an overview.

    J Sieper;J Braun;M Rudwaleit;A Boonen

  • Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis

    JÜRgen Braun;Matthias Bollow;Lucia Neure;Eva Seipelt

  • How to diagnose axial spondyloarthritis early

    M Rudwaleit;D van der Heijde;M A Khan;J Braun

Frequent Co-Authors

Joachim Sieper
Joachim Sieper Charité - University Medicine Berlin
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center
Xenofon Baraliakos
Xenofon Baraliakos Ruhr University Bochum
Martin Rudwaleit
Martin Rudwaleit Ghent University
Bernd Hamm
Bernd Hamm Charité - University Medicine Berlin
Joachim Listing
Joachim Listing Leibniz Institute for Neurobiology
Robert Landewé
Robert Landewé University of Amsterdam
Walter P. Maksymowych
Walter P. Maksymowych University of Alberta
Robert D. Inman
Robert D. Inman University of Toronto
Maxime Dougados
Maxime Dougados Hôpital Cochin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens the door to a wide variety of online pathways in healthcare and nursing. Many students are now considering flexible, online degree options that make it easier to balance learning with work or family obligations.

For those interested in advanced clinical roles, there are affordable online fnp programs designed for aspiring Family Nurse Practitioners. If you are looking to begin your nursing career or upgrade your qualification, you can explore the cheapest online bsn programs and cheapest bsn programs for cost-effective options.

For those seeking advanced leadership or teaching positions in nursing, consider the cheapest dnp online program. Each of these online pathways offers affordable, accredited options that can help you move forward in your healthcare career without taking on excessive debt.

Online programs make it possible to gain qualifications from accredited universities while maintaining flexibility—helping you achieve your professional goals faster and more cost-effectively.

Best Scientists Citing Jürgen Braun

Trending Scientists

Recently Published Articles